Clinical trials
Phase 3 Ischemia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Northland Biotech. Co., Ltd. | 2 |
| AstraZeneca | 1 |
| Neuroscience Trials Australia | 1 |
| Xuanwu Hospital, Beijing | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ischemia | 5 |
| Arterial Occlusive Diseases | 3 |
| Chronic Limb-Threatening Ischemia | 2 |
| Peripheral Vascular Diseases | 2 |
| Stroke | 2 |
| Ulcer | 2 |
| Brain Diseases | 1 |
| Brain Infarction | 1 |
| Brain Ischemia | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.